Cancer Screening Among Women Prescribed Opioids: A National Study

PURPOSE Prior work suggests that there are competing demands between addressing pain and other issues in primary care, potentially lessening delivery of evidence-based cancer screening. We assessed the association between opioid therapy and cancer screening among women in a nationally representative US sample. METHODS We conducted an observational analysis of the 2005-2015 Medical Expenditure Panel Surveys. We included all women aged ≥18 years without cancer and with opioid prescription and preventive care services data. Logistic regression analyses examined associations between receipt of opioid prescription (any vs none) and receipt of breast, cervical, and colorectal cancer screenings. Analyses were adjusted for sociodemographic characteristics, health status, health conditions, and usual source of care, as well as health care utilization. RESULTS Of 53,982 participants, 15.8% reported ≥1 opioid prescription. Compared with women not prescribed opioids, those prescribed opioids were more likely to visit their doctor (median number of visits per year = 5, vs 1). Without adjustment for number of visits, women prescribed opioids were more likely to receive all 3 cancer screenings; the adjusted odds ratio for breast cancer screening was 1.26 (95% CI, 1.16-1.38), that for cervical cancer screening was 1.22 (95% CI, 1.13-1.33), and that for colorectal cancer screening was 1.22 (95% CI, 1.12-1.33). With adjustment for number of visits, adjusted odds ratios decreased (breast 1.07 [95% CI, 0.98-1.18]; cervical 1.01 [95% CI, 0.93-1.09]; colorectal 1.04 [95% CI, 0.95-1.14]). CONCLUSIONS In a nationally representative sample, receipt of opioid prescriptions was not associated with less recommended cancer screenings. Rather, women receiving opioids had greater adjusted odds of receiving breast, cervical, and colorectal cancer screening, although the associations were attenuated by adjusting for their more frequent office visits relative to women not receiving opioids.

[1]  W. Rüther,et al.  Task force. , 2011, Midwives.

[2]  R. Shults,et al.  Opioid Prescribing in the United States. , 2018, The American journal of nursing.

[3]  Kathe P. Fox,et al.  Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study , 2018, British Medical Journal.

[4]  M. Beach,et al.  Prescription Opioid Use and Satisfaction With Care Among Adults With Musculoskeletal Conditions , 2018, The Annals of Family Medicine.

[5]  V. G. Lappi,et al.  Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews. , 2017, The Cochrane database of systematic reviews.

[6]  G. M. Allan,et al.  Competing demands and opportunities in primary care. , 2017, Canadian family physician Medecin de famille canadien.

[7]  L. Cottler,et al.  Sex differences in prescription opioid use , 2017, Current opinion in psychiatry.

[8]  B. Martin,et al.  Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use — United States, 2006–2015 , 2017, MMWR. Morbidity and mortality weekly report.

[9]  Rose A Rudd,et al.  Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015. , 2016, MMWR. Morbidity and mortality weekly report.

[10]  A. Jerant,et al.  Primary Care Attributes Associated with Receipt of Preventive Care Services: A National Study , 2015, The Journal of the American Board of Family Medicine.

[11]  B. Martin,et al.  The Role of Opioid Prescription in Incident Opioid Abuse and Dependence Among Individuals With Chronic Noncancer Pain: The Role of Opioid Prescription , 2013, The Clinical journal of pain.

[12]  E. Krebs,et al.  Contrasting tensions between patients and PCPs in chronic pain management: a qualitative study. , 2013, Pain medicine.

[13]  M. Beach,et al.  Increases in the Use of Prescription Opioid Analgesics and the Lack of Improvement in Disability Metrics Among Users , 2013, Regional Anesthesia & Pain Medicine.

[14]  K. Jordan,et al.  Opioid use among low back pain patients in primary care: Is opioid prescription associated with disability at 6-month follow-up? , 2013, PAIN®.

[15]  R. Chou,et al.  Medical and psychological risks and consequences of long-term opioid therapy in women. , 2012, Pain medicine.

[16]  Marianne S Matthias,et al.  The patient-provider relationship in chronic pain care: providers' perspectives. , 2010, Pain medicine.

[17]  James F. Calvert,et al.  Chronic Opioid Therapy and Preventive Services in Rural Primary Care: An Oregon Rural Practice-based Research Network Study , 2010, The Annals of Family Medicine.

[18]  S. Tregear,et al.  Long-term opioid management for chronic noncancer pain. , 2010, The Cochrane database of systematic reviews.

[19]  B. Psaty,et al.  Opioid Prescriptions for Chronic Pain and Overdose , 2010, Annals of Internal Medicine.

[20]  Elbert S. Huang,et al.  The Increasing Number of Clinical Items Addressed During the Time of Adult Primary Care Visits , 2008, Journal of General Internal Medicine.

[21]  M. French,et al.  Quality of Life Associated with Daily Opioid Therapy in a Primary Care Chronic Pain Sample , 2008, The Journal of the American Board of Family Medicine.

[22]  Jiang He,et al.  Mortality prediction with a single general self-rated health question , 2006, Journal of General Internal Medicine.

[23]  U. Richarz,et al.  Impact of long-term use of opioids on quality of life in patients with chronic, non-malignant pain , 2005, Current medical research and opinion.

[24]  Michael J. Cousins,et al.  Chronic pain and frequent use of health care , 2004, Pain.

[25]  Usha Sambamoorthi,et al.  Racial, ethnic, socioeconomic, and access disparities in the use of preventive services among women. , 2003, Preventive medicine.

[26]  Katrina M. Krause,et al.  Primary care: is there enough time for prevention? , 2003, American journal of public health.

[27]  K. Bertakis,et al.  Patient pain: its influence on primary care physician-patient interaction. , 2003, Family medicine.

[28]  R. Kerns,et al.  Use of opioid medications for chronic noncancer pain syndromes in primary care , 2002, Journal of General Internal Medicine.

[29]  Lorinda M. Sheppard,et al.  Why Physicians Are Unprepared to Treat Patients Who Have Alcohol‐ and Drug‐related Disorders , 2001, Academic medicine : journal of the Association of American Medical Colleges.

[30]  Karen B DeSalvo,et al.  Predicting mortality and healthcare utilization with a single question. , 2001, Health services research.

[31]  Mark Payne,et al.  Health and Human Services , 2020, Congress and the Nation 2013-2016, Volume XIV: Politics and Policy in the 113th and 114th Congresses.

[32]  Nikki R. Wooten,et al.  Opioid Prescription Drug Use and Expenditures in US Outpatient Physician Offices: Evidence from Two Nationally Representative Surveys. , 2017, Cancer therapy & oncology international journal.

[33]  Jie Chen,et al.  Preventive care utilization among the uninsured by race/ethnicity and income. , 2015, American journal of preventive medicine.

[34]  A. Holland,et al.  Agency for Healthcare Research and Quality: Health Literacy Universal Precautions Toolkit , 2013 .

[35]  K C Stange,et al.  Competing demands of primary care: a model for the delivery of clinical preventive services. , 1994, The Journal of family practice.

[36]  Marcia Valenstein,et al.  Association between Opioid Prescribing Patterns and Opioid Overdose-related Deaths Downloaded From: Http://jama.jamanetwork.com/ by a Penn State Milton S Hershey Med Ctr User on 08/01/2013 , 2022 .